000710 Berry Genomics
- 8.70
- +0.12+1.40%
Berry Genomics News
Berry Gene (000710.SZ): No big data artificial intelligence business yet
Gelonghui, April 30 | Berry Gene (000710.SZ) said on the investor interactive platform that the company is committed to the comprehensive transformation of gene sequencing technology to clinical application, focusing on reproductive health, genetic disease testing, tumor testing, scientific and technological services, etc., and there is no big data artificial intelligence business yet.
Berry Gene (000710.SZ): Committed to the comprehensive transformation of gene sequencing technology to clinical application, focusing on reproductive health, genetic disease testing, tumor testing, scientific and technological services
Gelonghui, April 30 | Berry Gene (000710.SZ) said on the investor interactive platform that the company is committed to the comprehensive transformation of gene sequencing technology to clinical application, focusing on reproductive health, genetic disease testing, tumor testing, scientific and technological services; for basic research services, the company has now established dozens of research product types covering library sequencing, animal and plant genome De novo, animal and plant genome re-sequencing, human genome re-sequencing, transcriptional regulation, single-cell transcriptomics, spatial proteomics, microbiology, etc. in cancer research, Genetic disease research, animal and plant research
Berry Gene (000710.SZ) announced its 2023 annual results, net loss of 427 million yuan, and loss increased
Berry Gene (000710.SZ) released its 2023 annual report. The company's revenue was 1.151 billion yuan,...
China Non-Invasive Prenatal Testing Market Research Report 2024-2032 Featuring Basetra, Berry Genomics, and BGI Diagnosis
China Genetic Testing Market Report 2024-2032 Featuring BGI, Berry Genomics, Daan Gene, WuXi NextCODE, Annoroad Gene Technology, and WuXi PharmaTech - ResearchAndMarkets.com
DUBLIN--(BUSINESS WIRE)--The "China Genetic Testing Market Report by Test Type, Disease, Technology, Service Provider, Testing Sample 2024-2032" report has been added to ResearchAndMarkets.com's offer
Express News | Berry Genes: Chromosome copy number variation test kit obtains medical device registration certificate
A-share changes丨The AI medical concept is repeatedly active, and the Berry gene is linked to 3 links
Gelonghui, March 20 | Berry Genomics and Celi Medical are on the 3rd board. Runda Healthcare hit a rise or fall, while Wanda Information, Hongbo Pharmaceuticals, and Sichuang Medical Benefits followed suit. According to the news, Novo Nordisk Foundation announced a few days ago that it has reached an agreement with Nvidia to build a superAI computer called “GEFION” for the Nordic country Denmark to lead the country into the AI field. Furthermore, at its annual health event “The Check Up,” Google announced a series of new initiatives to apply artificial intelligence (AI) models to the healthcare industry.
The AI medical concept continues to be strong, Saili Medical's 2-in-1
Gelonghui, March 19 | Celi Medical and Berry Genes are on the same page. Aladdin and Hongbo Pharmaceuticals rose more than 7%, while Yahong Pharmaceutical and Anbiping followed suit. According to the news, Nvidia launched 25 new microservices (NIM) based on medical scenarios at the GTC conference to help global healthcare companies improve efficiency based on generative AI.
Smart medicine and innovative drug concepts are active, and many stocks such as Berry Gene have risen and stopped
Gelonghui, March 18 | Hongbo Pharmaceutical rose more than 15%. Berry Gene, Jinan Hi-Tech, and Saili Medical rose and stopped, while Langma Information, Pharmaceutical Technology, Chengdu Pioneer, and Wisdom Pharmaceuticals rose ahead. According to news, at the Nvidia GTC conference, which will open on the 18th, there are 90 healthcare/life sciences-related events — the highest number of all industries, surpassing popular fields such as automobiles, cloud services, and hardware/semiconductors.
Berry Genomics to Sell Fujian Industrial Park Assets to New JV
Berry Genomics (SHE:000710) has agreed to sell assets related to its Fujian Industrial Park project to a newly established joint venture with Fuzhou Binhai Airport Development and Construction. The Ch
Berry Gene (000710.SZ): Fujian Berry plans to lease some houses in Berry Industrial Park to a joint venture for personal use and investment
Gelonghui, Feb. 4 | Berry Gene (000710.SZ) announced that Fujian Berry Hekang Gene Technology Co., Ltd. (“Fujian Berry”), a wholly-owned subsidiary of the company, plans to establish a joint venture with Fuzhou Binhai Airport Development and Construction Co., Ltd. (“Fuzhou Rinkong Construction”) and acquire Fujian Industrial Park assets held by Fujian Berry. According to the agreement between the two parties, after the joint venture was established and the asset acquisition was completed, Fujian Berry leased some of the houses in Berry Industrial Park to the joint venture for personal use and investment, and signed an “Industrial Park Lease Contract”. Among them, the rental period for personal use is 12 years, and the total rent is 7,4
Berry Gene (000710.SZ) issued an advance loss and is expected to have a net loss of 400 million yuan in 2023
Berry Gene (000710.SZ) announced its 2023 annual results forecast. It is expected to be owned by listed company shareholders for the whole year...
Berry Genomics (000710.SZ): The business does not currently involve diseases related to blood organofluoride compounds
Gelonghui, January 12 | Berry Gene (000710.SZ) said on the investor interactive platform that the company is committed to the comprehensive transformation of gene sequencing technology to clinical application, focusing on reproductive health, genetic disease testing, tumor testing, scientific and technological services, etc., and the business does not currently involve diseases related to blood organofluoride compounds.
The World Market for Molecular Diagnostics 12th Edition, Featuring Competitive Analysis of Advanced Cell Diagnostics, Berry Genomics, Biocartis, BioMerieux, CareDx, Danaher, Hologic, Illumina & More - ResearchAndMarkets.com
DUBLIN--(BUSINESS WIRE)--The "World Market for Molecular Diagnostics, 12th Edition" report has been added to ResearchAndMarkets.com's offering.Recent years saw molecular diagnostics emerge as the fast
Gene therapy may open a new chapter in the pharmaceutical field, and the industry has broad prospects for growth
① Gene therapy developer VoyagerTherapeutics has reached a strategic cooperation and licensing agreement with Novartis Pharmaceuticals subsidiaries to advance novel gene therapies for Huntington's disease and spinal muscular atrophy. ② The agency expects the global gene editing market to reach US$36.61 billion by 2030, with a compound annual growth rate of 22.3%.
Berry Genes (000710.SZ): Multi-modal AI is not involved yet
Glonghui December 15: Berry Gene (000710.SZ) stated on the investor interactive platform that the company independently developed the NLPearl genetic disease artificial intelligence clinical decision support system and the CNVisi intelligent report interpretation system to provide intelligent decision support for researchers and clinicians, and did not involve multi-modal AI yet.
Berry Gene (000710.SZ): Not yet involved in gene editing
Glonghui December 15 - Berry Gene (000710.SZ) stated on the investor interactive platform that gene sequencing technology can provide genetic data and support for gene editing. The company is committed to the comprehensive transformation of gene sequencing technology into clinical applications, and gene editing has not yet been involved.
Berry Gene (000710.SZ): No respiratory testing equipment yet
Glonghui, December 8: Some investors asked Berry Genes (000710.SZ) on the investor interactive platform, “Does the company have respiratory testing equipment?” The company replied that the company has no respiratory tract testing equipment yet.
Dragon Tiger List | Donghu Hi-Tech received a massive funding of 206 million yuan, and 3 institutions fled Shengtian Network for 131 million yuan
The top three net purchases on the Dragon Tiger list today are Donghu Hi-Tech, Yongxing Materials, and Soling Shares
Dragon Tiger List | Berry Genes fell 6.08%, and the four institutions had net sales of 85.9889 million yuan
Greenway, December 6 | Following yesterday's ups and downs, Berry Gene (000710.SZ) fell 6.08% from today's high, with a turnover of 1,315 billion yuan and a turnover rate of 28.31%. According to Dragon Tiger Ranking data, the Suzhou Central Plaza Sales Department of Shanghai Securities had a net sale of 87.3957 million yuan in order to sell one seat; the four institutions bought 246.5559 million yuan and sold 111 million yuan at the same time, with a net sale of 85.9889 million yuan. The seats on the list bought 81,4496 million yuan and sold 238 million yuan throughout the day, with a total net sales of 157 million yuan.
Analysis
Price Target
No Data
